Project R-9709
Title
PDE4D inhibition & pMS: IP valuation and valorization roadmaps (Research)
Abstract
UHasselt and Maastricht University/Academisch Ziekenhuis Maastricht have a patent application for the use of PDE4D inhibition as a therapy for progressive multiple sclerosis. In this project, a third party will be consulted to analyze the estimated market potential and the patent value. The different valorization roadmaps (license versus spin-off) will be evaluated in terms of next necessary steps, required budgets and chances for success (due diligence).
Period of project
01 April 2019 - 31 March 2020